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Abstract
A report about a disease problem in cultured whiteleg shrimp (Penaeus vannamei) was first received 
by the National Fish Health Research Center (NaFisH) in 2011 from Perak State showing signs of 
white feces and slow death leading to serious mortality rate. Later, in September of the same 
year, the Malaysian Shrimp Farmers Association (MSFA) reported to Department of Fisheries (DOF) 
severe mortalities in almost all of the whiteleg shrimp farms throughout Peninsular Malaysia. 
Sampling of shrimps for disease diagnosis was then conducted by NaFisH. The bacteriological 
and histopathological examinations revealed respectively the isolation of V. parahemolyticus and 
massive sloughing of hepatopancreatic epithelial cells. The disease was subsequently identified as 
acute hepatopancreatic necrosis disease (AHPND). From our 3-year study, the annual prevalence 
rates of AHPND were 50%, 26% and 73% in 2011, 2012 and 2013, respectively. At present, AHPND 
still persists in Malaysia but at a lower prevalence. The risk factors associated with the disease 
were studied, however, varied environmental and management data analyzed were inconclusive to 
relate any one parameter directly to the disease. To help ensure the early detection of AHPND, an 
experimental observation study on `gut scorecard’ was carried out and this was confirmed by PCR 
and histopathology. Validation of this technique has yet to be carried out to ensure its reliability. We 
also examined the potential use of some commercial products such as probiotics and disinfectants 
available in the market but unfortunately results showed that they were not effective in controlling 
AHPND. Control measures applied by the farmers such as the use of probiotics were also verified 
but data generated likewise appeared to be inconclusive. On the contrary, our preliminary study 
on the antibacterial property of the plant extracts, i.e. betel and lemongrass, incorporated in 
the feed showed some prophylactic and chemotherapeutic potential against AHPND. However, 
comprehensive in vitro and in vivo trials are still currently being undertaken to elucidate its efficacy 
and practical applications. To ensure the shrimp industry’s sustainability in Malaysia, results of our 
ongoing and future studies aimed at preventing and controlling unwarranted outbreaks of AHPND 
and other emerging transboundary diseases of penaeid shrimps will be continually disseminated 
to shrimp farmers and pertinent stakeholders. 
56 Addressing acute hepatopancreatic necrosis disease (AHPND) and other transboundary 
diseases for improved aquatic animal health in Southeast Asia
Introduction 
The whiteleg shrimp (Penaeus vannamei) is a 
popular choice species for shrimp farmers in 
Malaysia. Whiteleg shrimp culture started in 
Peninsular Malaysia in 2002. The  contributions 
of whiteleg shrimp and tiger prawn (P. monodon) 
in annual production of farmed shrimps were 
70% and 30%, respectively in 2007 (Annual 
Fisheries Statistics, 2005-2014). They have 
been successfully cultured in earthen ponds. 
However, in the latter part of 2010 and early part 
of 2011, farmers in the southern and middle 
regions of Peninsular Malaysia encountered 
several disease outbreaks during the early stage 
of shrimp culture. At that time, the outbreak 
was known as early mortality syndrome 
(EMS) or acute hepatopancreatic necrosis 
syndrome (AHPNS). Early mortality syndrome 
was later named as acute hepatopancreatic 
necrosis disease (AHPND) in 2013 (Tran et al., 
2013). AHPND is caused by a unique strain of 
Vibrio parahaemolyticus capable of releasing 
potent toxins that could consequently lead 
to tissue destruction and dysfunction of the 
hepatopancreas (GAA, 2013). 
Outbreaks of AHPND among the major whiteleg 
shrimp-producing farms located in five major 
states in Peninsular Malaysia had consequently 
resulted in serious economic losses estimated 
at USD 0.1 billion in 2011 (NACA 2012). In the 
course of our investigation, i.e. from 2011 to 
2013, we found out that AHPND had caused 40 
to 100% mortality of cultured whiteleg shrimps. 
We also discovered that some surviving whiteleg 
shrimps had slow growth that subsequently 
succumbed to morbidity and mortality at the 
latter stage of culture. Occurrence of AHPND 
has been reported in China (2009), Viet Nam 
(2011), Thailand (2012) and the Philippines 
(2015) (Tran et al., 2013; Joshi et al., 2014; 
dela Peña et al., 2015). Apart from these Asian 
countries, AHPND has also been reported in 
Mexico in 2013 (Lightner et al., 2013; Soto-
Rodriguez et al., 2015). AHPND has caused 
significant reduction in the world shrimp 
production (NACA, 2013; FAO, 2013; Lightner 
et al., 2012; Leaño and Mohan, 2012). 
In Malaysia, investigations on AHPND 
episodes since 2011 have been accordingly 
categorized into 5 phases. Phase I was 
conducted in 2011 with the main objective 
of identifying the etiology of the disease. 
Phase II on the other hand, delved on factors 
associated with AHPND outbreaks. Moreover, 
Phase III focused on control and preventive 
measures. Finally, Phases IV and V have been 
concurrently conducted to generate substantial 
data on the epidemiology of AHPND, establish 
practical and accurate methods for the early 
detection of AHPND at the farm level, and 
develop practical and effective preventive and 
therapeutic methods through the use of herbs 
or environment friendly products with potent 
antibacterial properties.
History of occurrence
In the mid 2011, the Fisheries Research 
Institute through the National Fish Health 
Research Division (NaFisH) received reports 
of two cases of cultured whiteleg shrimps 
exhibiting white feces and slow death from 
shrimp operators in Perak State. Subsequently, 
the Department of Fisheries (DOF) of Malaysia 
was informed by the Malaysian Shrimp 
Farmers Association (MSFA) of high mortalities 
at alarming rates in most of the shrimp farms 
located throughout Peninsular Malaysia 
in September 2011. An immediate action 
was undertaken to determine the possible 
cause or etiology of the outbreak. Water and 
shrimps from affected areas were sampled and 
diagnosed for diseases. Relevant water quality 
parameters were also determined. During the 
course of our investigation, we discovered that 
the outbreak actually occurred in the east coast 
of Johor in the latter part of 2010. However, no 
samples were obtained from Johor during that 
period because before the sampling was about 
to be carried out, farmers had already done an 
emergency harvest. In 2011, the affected States 
included Perak, Penang, Kedah and Pahang. 
The etiology of the disease was later confirmed 
as AHPND based on histopathological changes 
in the hepatopancreas of affected shrimps and 
affirmation of the diagnostic finding by the 
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laboratory of Dr. D. Lightner in Arizona State 
University. Subsequently, samples from Sabah 
and Sarawak (2012), Terengganu (2013), 
Melaka and Johor (2014) States were also 
found positive for AHPND by histopathology 
(Figure 1).
respectively (Annual Fisheries Statistics, 2005-
2014). Based on the estimated total shrimp 
production losses from 2011 to 2014, the total 
economic losses from AHPND episodes were 
estimated to reach USD 0.49 billion. 
Species affected 
Currently, two major species of farmed shrimps, 
i.e. whiteleg shrimp (P. vannamei) and tiger 
prawn (P. monodon), have been so far affected 
by AHPND resulting in serious mortalities. 
It was first detected in whiteleg shrimp and 
tiger prawn in 2011 and 2014, respectively. 
Infection rate was higher in whiteleg shrimp 
than tiger prawn. AHPND was documented in 
shrimp post larvae (PL) 7 to 12, juveniles, and 
broodstocks. 
Disease signs and diagnostic methods
On-farm investigations of shrimps for AHPND 
diagnosis are usually conducted in farms 
experiencing mortality within 30 days of 
stocking shrimps in cultivation ponds or when 
large-scale die-offs commence. Shrimps infected 
with AHPND exhibit an array of clinical signs 
including lethargy, soft shells, whitish muscle, 
empty stomach and midgut, slow growth, 
and pale atrophied hepatopancreas that often 
have black streaks. However, these pond-level 
observations have to be further diagnostically 
confirmed as AHPND by taking into account 
Figure 1. Chronological order (year) of AHPND 
occurrences in Malaysia confirmed by histopathology
Figure 2. Production of farmed shrimps in Malaysia from 2005 to 2014 and corresponding losses estimated from the 
reduction of shrimp production.
Severity and economic impact
Total production of cultured shrimp was 
87,000 metric tons (MT) in 2010 and 90% of 
the production was contributed by whiteleg 
shrimps (Figure 2). Several outbreaks of 
AHPND in whiteleg shrimp farms in 2011, 
2012 and 2013 resulted in the reduction of 
total shrimp production to 67,000 MT, 55,000 
MT, and 50,000 MT in 2011, 2012, and 2013, 
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the pathognomonic histopathological signs 
of AHPND including the isolation of V. 
parahaemolyticus (biochemically identified 
using API20E) and massive sloughing of 
hepatopancreatic tubule epithelial cells of the 
hepatopancreas of affected shrimps. From 
2013 onwards, PCR assay using primers AP2, 
AP3 and AP4, Real-time PCR, and detection kit 
(IQ2000) have been employed as confirmatory 
tests for AHPND.  
Status of AHPND
The current status of AHPND in farmed 
shrimps in Malaysia is chiefly based on the 
histopathological findings generated from 
the number of mortality cases reported to 
NaFisH, shrimp diagnostic laboratories, and 
epidemiological work carried out from 2011 
to 2015.  A total of 4,571 samples of farmed 
whiteleg shrimps and tiger prawns were 
obtained from 3 main diagnostic laboratories. 
The 3 main diagnostic laboratories receiving 
samples monthly include NaFisH, Fisheries 
Research Institute, and a private laboratory. 
The positive cases of AHPND in whiteleg shrimp 
were 50%, 26%, 34%, 13% and 4% in 2011, 2012, 
2013, 2014 and 2015, respectively (Table 1). 
AHPND was also detected in tiger prawn in 
2014 (10%) and 2015 (5%), respectively. At 
present, AHPND still persists in Malaysia but 
at a lower prevalence. 
Future directions
Research and development focusing on the 
early detection of AHPND at the farm level 
and usage of alternative treatment such as 
the use herb extracts or environment-friendly 
products have been carried out since 2013. 
The risk factors associated with the disease 
have been also studied, however variations 
in environmental and management data 
revealed to be inconclusive to relate any 
one parameter directly to the occurrence of 
AHPND. To assist early detection of AHPND in 
cultivated shrimps, experimental observation 
study on ‘gut scorecard’ has been carried 
out together with PCR and histopathology as 
confirmatory tests. However, validation of this 
technique to ensure its validity and reliability 
is ongoing. Studies on control measures have 
been also conducted at the farm level through 
a collaborative effort with the farmers using 
existing commercial products but the results 
showed that these commercial products were 
ineffective in controlling AHPND. Also, control 
measures formulated by the farmers themselves 
such as the use of probiotics were analyzed but 
most of these methods were likewise found 
to be ineffective. However, our laboratory 
trial using the betel and lemongrass extracts 
incorporated in the shrimp’s diet conferred 
protection against an experimental challenge 
with V. parahaemolyticus strains implicated in 
outbreaks of AHPND in Malaysia. However, 
Table 1. Samples of whiteleg shrimps and tiger prawns examined for AHPND from 2011 to 2015.
Year

















2011 394 197 50.0
2012 584 151 25.9
2013 661 212 34.4
2014 1,586 199 12.5 50 5 10.0
2015 1,346 50 3.7 74 4 5.4
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more comprehensive studies still need to be 
conducted to elucidate its efficacy and practical 
applications. Aside from the imposition of 
stringent biosecurity measures in hatcheries 
and grow-out facilities, to realistically ensure 
the sustainability of the shrimp industry in 
Malaysia, results of our ongoing and future 
studies aimed at preventing and controlling 
unwarranted outbreaks of AHPND and other 
emerging transboundary diseases of penaeid 
shrimps will be continually disseminated to 
shrimp farmers and pertinent stakeholders. 
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